Search Results

34 Results for "abvitro".

Sort By

Press Releases

NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS

February 17, 2025
·
4 min read
Press Releases

Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion

November 6, 2024
·
4 min read
Deals

Juno Pays $125 Million for Harvard Spinout AbVitro

January 11, 2016
·
7 min read
Genetown

AbVitro To Present At The American Association for Cancer Research Annual Meeting

April 16, 2015
·
2 min read
Genetown

AbVitro To Provide Academic Institutions Access To Its AbPair Technology Through A Grant Challenge Program

August 20, 2015
·
3 min read
Business

AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. As CEO

October 23, 2014
·
2 min read
Business

AbVitro Appoints Samuel Broder, M.D., To Its Board Of Directors And Scientific Advisory Board

November 4, 2014
·
2 min read
Deals

Roche Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline

October 9, 2014
·
3 min read
Deals

Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond

Santé Ventures, an early-stage healthcare and life sciences investment firm, has announced the acquisition of its Fund III portfolio company, Laminar, Inc., by Johnson & Johnson Medtech.

November 30, 2023
·
3 min read
Genetown

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets

Solu Therapeutics today announced the closing of an oversubscribed $31 million seed financing co-led by Longwood and Santé Ventures, with additional participation from DCVC Bio, Astellas Venture Management, and Alexandria Venture Investments.

August 1, 2023
·
5 min read